Noubar Afeyan: Our partnership with Novo Nordisk brings together the best of two companies in drug development
Noubar Afeyan, Founder and CEO of Flagship Pioneering, shared a post by Flagship Pioneering on LinkedIn, adding: .
“Our partnership with Novo Nordisk brings together the best of two companies to accelerate innovation in drug development and create new medicines for patients who need them.
The partnership with Flagship-founded Metaphore Biotechnologies announced today is the third research collaboration announced under this Innovation Supply Chain partnership. Together this collaboration will advance potential new therapies to address obesity management.”
Quoting Flagship Pioneering’s post:
“Today we announce a new research collaboration as part of our strategic partnership with Novo Nordisk.
Flagship-Founded Metaphore Biotechnologies will partner closely with our Pioneering Medicines team and with Novo-Nordisk to develop up to two next-generation therapeutics leveraging GLP-1R and related biology for obesity management. Read more here.”
Source: Noubar Afeyan/LinkedIn and Flagship Pioneering/LinkedIn